Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 6/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.33 |
| ▸ | CASP2 | P42575 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25768096 | 0.97 | EPHX1 (0.34) | EPHX1KDM4EMAPK1HIF1ACA12 | |
| SCHEMBL2563904 | 0.95 | CA12 (0.32) | EPHX1CA12CA1CA2CA9 | |
| SCHEMBL4534944 | 0.94 | EPHX1 (0.42) | EPHX1EPHX2CASP2FAAH | |
| SCHEMBL14672658 | 0.94 | EPHX1 (0.42) | EPHX1EPHX2CASP2FAAH | |
| SCHEMBL23373135 | 0.91 | EPHX1 (0.42) | EPHX1EPHX2CASP2FAAH | |
| SCHEMBL1203085 | 0.89 | EPHX1 (0.40) | EPHX1EPHX2CASP2FAAH | |
| SCHEMBL13934745 | 0.89 | EPHX1 (0.40) | EPHX1EPHX2CASP2FAAH | |
| SCHEMBL29837984 | 0.89 | EPHX1 (0.40) | EPHX1EPHX2CASP2FAAH | |
| SCHEMBL21924930 | 0.89 | EPHX1 (0.30) | EPHX1 | |
| SCHEMBL21924986 | 0.88 | EPHX1 (0.35) | EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2138501-B1 | Functional silane compound, coating solution, and method for manufacturing plastic lens | HOYA CORP (JP) | 2014-08-13 | — | — | EP | disclosed |
| US-20090317541-A1 | FUNCTIONAL SILANE COMPOUND, COATING SOLUTION, AND METHOD FOR MANUFACTURING PLASTIC LENS | HOYA CORPORATION (JP) | 2009-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090317541-A1 | FUNCTIONAL SILANE COMPOUND, COATING SOLUTION, AND METHOD FOR MANUFACTURING PLASTIC LENS | SUMO1, CAD, UFM1 | EPHX1 4148/4885KDM4E 732/4885MAPK1 1743/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.